About the bill
- Full Title
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Mar 25, 2009
- What is a bill?
The “H.R.” in “H.R. 1902” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
13 cosponsors (13D) (show)(joined Apr 17, 2007)(joined Apr 17, 2007)(joined Apr 17, 2007)(joined Apr 17, 2007)(joined Apr 17, 2007)(joined Apr 17, 2007)(joined Apr 25, 2007)(joined Apr 26, 2007)(joined May 1, 2007)(joined May 9, 2007)(joined May 9, 2007)(joined May 16, 2007)(joined Dec 6, 2007)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 1902 — 110th Congress: Protecting Consumer Access to Generic Drugs Act of 2007. Retrieved from https://www.govtrack.us/congress/bills/110/hr1902
“H.R. 1902 — 110th Congress: Protecting Consumer Access to Generic Drugs Act of 2007.” www.GovTrack.us. 2007. May 27, 2015 <https://www.govtrack.us/congress/bills/110/hr1902>
|title=H.R. 1902 (110th)
|accessdate=May 27, 2015
|author=110th Congress (2007)
|date=April 17, 2007
|quote=Protecting Consumer Access to Generic Drugs Act of 2007